SpineGuard and XinRong Medical Group announced the placement of a large purchase order of PediGuard devices and the completion of a capital increase primarily intended to fund the registration of the whole SpineGuard product portfolio by the Chinese NMPA (National Medical Product Administration). In line with the extended distribution agreement announced on May 16, XinRong Medical placed a purchase order for 448 Straight PediGuard units. In parallel, SpineGuard appointed a third-party regulatory agent, with XinRongâs input, to execute the Chinese registration of the other versions of PediGuard i.e. the Curved, the XS, the Canulated and the Threaded spinal drilling probes embedding SpineGuardâs DSG (Dynamic Surgical Guidance) technology.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2325 EUR | -0.43% | +4.03% | +16.48% |
Apr. 17 | SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | SpineGuard SA announced that it expects to receive ?1.998 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+16.48% | 11.89M | |
+73.37% | 12.39B | |
-17.09% | 8.08B | |
+16.88% | 7.25B | |
+3.57% | 5.86B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4.19B | |
-35.26% | 2.44B | |
+3.09% | 2.07B |
- Stock Market
- Equities
- ALSGD Stock
- News SpineGuard
- XinRong Medical places a large purchase order of PediGuard® devices and invests in SpineGuard to boost DSG® technology’s deployment in China